Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Serum cholesterol levels and the risk of Parkinson's disease.

de Lau LM, Koudstaal PJ, Hofman A, Breteler MM.

Am J Epidemiol. 2006 Nov 15;164(10):998-1002. Epub 2006 Aug 11.

PMID:
16905642
2.

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, Suzuki Y, Okamoto K, Yamamoto Y.

J Neurol Sci. 2004 Aug 30;223(2):161-6.

PMID:
15337618
3.

Serum uric acid levels and the risk of Parkinson disease.

de Lau LM, Koudstaal PJ, Hofman A, Breteler MM.

Ann Neurol. 2005 Nov;58(5):797-800.

PMID:
16240356
4.

Serum levels of coenzyme Q10 in patients with Parkinson's disease.

Jiménez-Jiménez FJ, Molina JA, de Bustos F, García-Redondo A, Gómez-Escalonilla C, Martínez-Salio A, Berbel A, Camacho A, Zurdo M, Barcenilla B, Enríquez de Salamanca R, Arenas J.

J Neural Transm (Vienna). 2000;107(2):177-81.

PMID:
10847558
5.

Prospective study of coffee consumption and risk of Parkinson's disease.

Sääksjärvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Männistö S.

Eur J Clin Nutr. 2008 Jul;62(7):908-15. Epub 2007 May 16.

PMID:
17522612
6.

Type 2 diabetes and the risk of Parkinson's disease.

Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J.

Diabetes Care. 2007 Apr;30(4):842-7. Epub 2007 Jan 24.

PMID:
17251276
7.

Incidence and risk factors of Parkinson's disease in The Netherlands.

Hofman A, Collette HJ, Bartelds AI.

Neuroepidemiology. 1989;8(6):296-9.

PMID:
2586699
8.

Total cholesterol and the risk of Parkinson disease.

Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J.

Neurology. 2008 May 20;70(21):1972-9. doi: 10.1212/01.wnl.0000312511.62699.a8. Epub 2008 Apr 9.

PMID:
18401018
9.

[Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].

Molina-Arjona JA, de Bustos F, Benito-León J, Jiménez-Jiménez FJ, Rodríguez J, Trincado R, Porta-Etessan J, Vega S, Bermejo F.

Rev Neurol. 1999 Jul 1-15;29(1):12-5. Spanish.

PMID:
10528302
10.

Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease.

Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM.

Am J Epidemiol. 1996 Sep 1;144(5):480-4.

PMID:
8781463
11.

Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.

de Lau LM, Stricker BH, Breteler MM.

Mov Disord. 2007 Oct 15;22(13):1985. No abstract available.

PMID:
17557354
12.

Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study.

Breteler MM, de Groot RR, van Romunde LK, Hofman A.

Am J Epidemiol. 1995 Dec 15;142(12):1300-5.

PMID:
7503050
13.

Body mass index and risk of Parkinson's disease: a prospective cohort study.

Logroscino G, Sesso HD, Paffenbarger RS Jr, Lee IM.

Am J Epidemiol. 2007 Nov 15;166(10):1186-90. Epub 2007 Aug 20.

PMID:
17709328
14.

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.

Shults CW, Flint Beal M, Song D, Fontaine D.

Exp Neurol. 2004 Aug;188(2):491-4.

PMID:
15246848
15.

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, Manubens-Bertran JM, Alpérovitch A, Rocca WA.

J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10-5.

16.

Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

Férnandez-Calle P, Molina JA, Jiménez-Jiménez FJ, Vázquez A, Pondal M, García-Ruiz PJ, Urra DG, Domingo J, Codoceo R.

Neurology. 1992 May;42(5):1064-6.

PMID:
1579230
17.

Hypothalamic digoxin-mediated model for Parkinson's disease.

Kurup RK, Kurup PA.

Int J Neurosci. 2003 Apr;113(4):515-36.

PMID:
12856480
18.

Number of children and risk of Parkinson's disease.

Frigerio R, Breteler MM, de Lau LM, Sanft KR, Bower JH, Ahlskog JE, Grossardt BR; Mariza de Andrade, Maraganore DM, Rocca WA.

Mov Disord. 2007 Apr 15;22(5):632-9.

PMID:
17265462
19.

Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients.

Cadoni G, Scipione S, Agostino S, Addolorato G, Cianfrone F, Leggio L, Paludetti G, Lippa S.

Otol Neurotol. 2007 Oct;28(7):878-83.

PMID:
17558340
20.

Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication.

Buhmann C, Arlt S, Kontush A, Möller-Bertram T, Sperber S, Oechsner M, Stuerenburg HJ, Beisiegel U.

Neurobiol Dis. 2004 Feb;15(1):160-70.

PMID:
14751781

Supplemental Content

Support Center